About Us

The lab employs advanced molecular techniques to monitor treatment efficacy, identify targeted therapies, and discover biomarkers to guide treatment decisions and enhance patient outcomes across various cancer types, primarily lung cancer.

Mission

Innovating and leveraging liquid biopsy technologies to transform cancer diagnostics and disease monitoring.

Accelerating the transition from biomarker discovery to clinically actionable applications.

Promoting collaborative research and supporting the professional and academic growth of all lab members.

  • Innovating and leveraging liquid biopsy technologies to transform cancer diagnostics and disease monitoring.
  • Accelerating the transition from biomarker discovery to clinically actionable applications.
  • Promoting collaborative research and supporting the professional and academic growth of all lab members.
Christian Rolfo, director of Division of Medical Oncology, and team at the Biomedical Research Tower

Vision

The Rolfo Lab envisions a future in which cancer treatment is personalized, highly effective, minimally invasive, and universally accessible. Our ultimate goal is the complete eradication of cancer through the continuous advancement of precision medicine strategies, tailored to meet the dynamic needs of patients worldwide.